CN Stock MarketDetailed Quotes

002294 Shenzhen Salubris Pharmaceuticals

Watchlist

30.03
+0.54+1.83%

Not Open Mar 6 15:00 CST

33.48BMarket Cap54.80P/E (TTM)

Shenzhen Salubris Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Shenzhen Salubris Pharmaceuticals Q4 2024 Estimates Date

Currency：CNYMar 29, 2025

	Estimate	YoY
EPS	0.14	+55.56%

Analyst Rating

Strong Buy

Mar 6, 2025

Shenzhen Salubris Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
Oct 29, 2019	2019/Q3	1.208B / 1.278B	--
Aug 27, 2019	2019/Q2	1.168B / 1.229B	--
Apr 23, 2019	2019/Q1	1.189B / 1.229B	--

DatePeriodRevenue/EstimateEarnings Call

Oct 29, 20192019/Q31.208B / 1.278B--

Aug 27, 20192019/Q21.168B / 1.229B--

Apr 23, 20192019/Q11.189B / 1.229B--

--------

Unlock Free Earnings Estimates

Open Account

Shenzhen Salubris Pharmaceuticals Earnings Reports

Xinlitai: Report for the third quarter of 2024

Oct 21, 2024 12:00 ET

Xinlitai: 2024 Semi-Annual Report Summary

Aug 26, 2024 12:00 ET

Xinlitai: 2024 Semi-Annual Report